
How a New Family of Drugs Can Work for Alzheimer’s Patients
A new class of drugs targets brain proteins to fight the effects of Alzheimer’s Disease.


A new class of drugs targets brain proteins to fight the effects of Alzheimer’s Disease.

New Alzheimer’s blood test speeds diagnosis, backed by UNLV Brain Health research data.

We talk to UNLV Department of Brain Health’s Dr. Jeffrey Cummings.

A five year study on Ozempic’s impact in delaying the progression of Alzheimer’s disease has ended.
